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CentroacinarThe Notch signaling pathway regulates embryonic development of the pancreas, inhibiting progenitor differ-
entiation into exocrine acinar and endocrine islet cells. The adult pancreas appears to lack progenitor cells,
and its mature cell types are maintained by the proliferation of pre-existing differentiated cells. Nonetheless,
Notch remains active in adult duct and terminal duct/centroacinar cells (CACs), in which its function is un-
known. We previously developed mice in which cells expressing the Notch target gene Hes1 can be labeled
and manipulated, by expression of Cre recombinase, and demonstrated that Hes1+ CACs do not behave as ac-
inar or islet progenitors in the uninjured pancreas, or as islet progenitors after pancreatic duct ligation. In the
current study, we assessed the function of Notch signaling in the adult pancreas by deleting the transcription
factor partner of Notch, Rbpj, speciﬁcally in Hes1+ cells. We ﬁnd that loss of Rbpj depletes the pancreas of
Hes1-expressing CACs, abrogating their ongoing contribution to growth and homeostasis of more proximal
duct structures. Upon Rbpj deletion, CACs undergo a rapid transformation into acinar cells, suggesting that
constitutive Notch activity suppresses the acinar differentiation potential of CACs. Together, our data provide
direct evidence of an endogenous genetic program to control interconversion of cell fates in the adult
pancreas.
© 2011 Elsevier Inc. All rights reserved.Introduction
The adult pancreas experiences relatively little cell turnover during
normal homeostasis, and most evidence to date indicates that its cell
types are maintained by faithful replication of pre-existing cells. In en-
docrine islets, replication is the main mode of generating new insulin-
producing β-cells (Brennand et al., 2007; Dor et al., 2004; Georgia and
Bhushan, 2004; Teta et al., 2007). Replication also appears to be the
mechanism by which acinar cells, belonging to the exocrine pancreas,
are maintained during homeostasis and regeneration (Desai et al.,
2007; Strobel et al., 2007). Although it remains controversial whether
adult stem or progenitor cells contribute to maintenance and repair of
the pancreas, embryonic pancreatic organogenesis relies on multipo-
tent and lineage-restricted progenitor cells, the differentiation of
which is controlled by intrinsic and extrinsic factors (reviewed in Pan
and Wright, 2011). Notch signaling is a major regulator of progenitor
cell differentiation, in the embryonic pancreas as well as numerous
other developing and adult tissues (Chiba, 2006). Although Notch ap-
pears to be active in the adult pancreas, its potential contribution to tis-
sue homeostasis is unknown and is the focus of this study.urtaugh).
rights reserved.The Notch pathway is activated by juxtacrine interactions be-
tween Delta/Serrate family ligands and Notch family receptors,
which trigger the protease-induced release and nuclear translocation
of the Notch intracellular domain (NIC). Nuclear NIC binds the tran-
scription factor Su(H)/CSL/Rbpjκ (henceforth referred to as Rbpj),
and co-activates target genes including the Hes/Hey family of tran-
scriptional repressors (Kageyama et al., 2007; Kopan and Ilagan,
2009). A central output of Notch signaling, across tissues and phyla,
is control of cell fate (Chiba, 2006), and Notch activation in the em-
bryonic pancreas inhibits acinar and islet cell differentiation while
promoting development of duct cells (Esni et al., 2004; Hald et al.,
2003; Kopinke et al., 2011; Murtaugh et al., 2003; Yee et al., 2005).
In the mature pancreas, gain-of-function studies suggest that Notch
signaling promotes acinar cell transdifferentiation to duct or
progenitor-like cells (De La O et al., 2008; Miyamoto et al., 2003;
Mukhi and Brown, 2011). Whether endogenous Notch plays such a
role remains unclear, as the only phenotype observed after pan-
pancreatic deletion of the Notch1 receptor is impaired regeneration of
adult acinar cells (Siveke et al., 2008). Nonetheless, Notch signaling ap-
pears to be active in the adult pancreas, as evidenced by expression of
its target gene Hes1 in centroacinar cells (CACs) and ducts (Kopinke et
al., 2011; Miyamoto et al., 2003; Parsons et al., 2009; Stanger et al.,
2005). CACs constitute the terminal element of the ductal tree and are
characterized by their central position within individual acinar rosettes
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adult progenitor-like cell in the pancreas and to produce new β-cells
following injury (Hayashi et al., 2003; Nagasao et al., 2003) and in
vitro (Rovira et al., 2010). Whether CACs actually behave as adult pro-
genitor cells in vivo has remained controversial, as tools for lineage trac-
ing these cells have been lacking until now.
We recently generated a tamoxifen-inducible Cre line under the
control of the Hes1 promoter (Hes1CreERT2, abbreviated Hes1C2),
which faithfully marks Hes1+ CACs (Kopinke et al., 2011). Lineage
tracing experiments in adult mice indicate that adult Hes1+ CACs do
not normally contribute to new β-cells or acini. In utero, however,
Hes1+ cells represent bipotent exocrine progenitors in which ectopic
Notch promotes duct speciﬁcation at the expense of acinar fate
(Kopinke et al., 2011). Thus, sustained Notch signaling in Hes1+
CACs might enforce their ductal fate and restrain their full differenti-
ation potential. In the current study, we challenge the system by dis-
rupting Notch signaling speciﬁcally in Hes1-expressing cells, and
demonstrate that Notch controls interconversion of cell fates in the
adult pancreas.
Material and methods
Animal experiments
Hes1C2 (Kopinke et al., 2011), R26REYFP (Srinivas et al., 2001) and
Rbpjlox (Han et al., 2002) mice have been described previously.
Ptf1aCre-ERTM mice were generated by recombinase-mediated cassette
exchange (Burlison et al., 2008), inserting the Cre-ERTM coding re-
gion (Danielian et al., 1998) into the ﬁrst exon of Ptf1a (full details
of this allele will be published elsewhere). Rbpjloxmice, kindly provid-
ed by Tasuku Honjo (Kyoto University, Kyoto, Japan) and Sean Morri-
son (University of Michigan, Ann Arbor, MI), were crossed to Hprt-Cre
deletor mice (Tang et al., 2002) to generate a null (RbpjΔ) allele. PCR
genotyping for the ﬂoxed allele of Rbpj was performed as described
(Han et al., 2002); for the null allele, the following oligos were
used: forward 5′-TAACTATCTTGGAAGGCTAAAAT-3′ and reverse 5′-
GCTTGAGGCTTGATGTTCTGTATTGC-3′ (598 bp product).
Tamoxifen (Sigma T-5648) was dissolved in corn oil, and adminis-
tered by oral gavage at doses of 5 mg (Ptf1aCre-ERTM) or 10 mg
(Hes1C2) per mouse between 6 and 8 weeks of age. BrdU (Sigma)
was dissolved in drinking water (1 mg/ml) and provided to mice ad
libitum, beginning 3 days prior to tamoxifen administration and con-
tinuing for 7 days thereafter. All animal procedures were approved by
the Institutional Animal Care and Use Committee of the University of
Utah.
Staining and analysis
Immunostaining and analysis were performed as previously de-
scribed (Kopinke and Murtaugh, 2010; Kopinke et al., 2011). The fol-
lowing primary antibodies were used: sheep anti-amylase 1:2500
(BioGenesis), rat anti-BrdU 1:2000 (Abcam), rabbit anti-cytokeratin-
19 1:1500 (gift from Ben Stanger, University of Pennsylvania, Phila-
delphia, PA), rabbit monoclonal anti-cytokeratin-19 1:500 (Epi-
tomics), rat anti-cytokeratin-19 1:50 (Developmental Studies
Hybridoma Bank), rabbit anti-cleaved Caspase3 1:1000 (Cell Signal-
ing), rat anti-E-cadherin 1:2000 (Zymed), rabbit anti-GFP 1:4000
(Abcam), goat anti-GFP 1:2500 (Rockland), guinea pig anti-glucagon
1:2500 (Linco), rabbit anti-glucagon 1:2500 (Zymed), guinea pig
anti-insulin 1:2000 (Dako), rabbit anti-Ki67 1:150 (Vector labs) and
rabbit anti-Ptf1a 1:800 (gift from Helena Edlund, Umea University,
Umea, Sweden). All secondary antibodies (raised in donkey) were
obtained from Jackson Immunoresearch. For Ki67 and BrdU immuno-
ﬂuorescence, a 15 min DNase I digestion (700 U/μl, in 40 mM Tris–
HCl pH 7.4, 10 mM NaCl, 6 mM MgCl2, and 10 mM CaCl2) was neces-
sary (Ye et al., 2007). Periodic Acid Schiff (PAS) staining was carriedout according to the manufacturer's instructions (Sigma). For quanti-
ﬁcations, co-immunoﬂuorescence was determined using the Analyze
Particles function of ImageJ (NIH) and conﬁrmed by eye in Adobe
Photoshop. Calculations and graphs were generated with Microsoft
Excel and R (www.r-project.org). P-values were determined by
Tukey's HSD test in R, and data are represented as mean±SEM. The
numbers of mice used for each experiment are indicated in each
graph. Acinar dissociation was performed as previously described
(Kopinke and Murtaugh, 2010). The total number of cells counted
for each graph is listed in Table S1.
Results
Hes1-speciﬁc deletion of Rbpj in adult intestine and pancreas
Rbpj encodes the transcription factor through which Notch acti-
vates target genes (Kopan and Ilagan, 2009). To determine a potential
role for Notch signaling in Hes1+ cells of the adult pancreas, we used
our inducible Hes1CreERT2 line (Hes1C2) to delete a ﬂoxed Rbpj allele
(Han et al., 2002; Kopinke et al., 2011). Our breeding scheme
(Fig. 1A) yielded both Hes1C2/+;Rbpjlox/+ mice, which are heterozy-
gous for the ﬂoxed allele (henceforth referred to as RbpjHes1-lox), and
Hes1C2/+;Rbpjlox/Δ animals, which carry a null (Δ) and a ﬂoxed allele
of Rbpj (RbpjHes1-cKO). All genotypes also included an R26REYFP reporter
(Srinivas et al., 2001), to follow the fate of recombined cells (see
below). RbpjHes1-cKO mice reached adulthood at a Mendelian ratio, and
were indistinguishable fromwild-type or RbpjHes1-lox animals before ta-
moxifen (TM) administration. It should be noted, however, that
RbpjHes1-cKO animals are compound heterozygotes for two major Notch
components,Hes1 and Rbpj. As an additional control, therefore, we gen-
erated mice that were heterozygous for the null rather than the ﬂoxed
allele of Rbpj (Hes1C2/+;R26REYFP/+;RbpjΔ/+; referred to as RbpjHes1-het).
Comparisons between these mice and RbpjHes1-cKO allowed us to distin-
guish potential phenotypes caused by compound Hes1/Rbpj heterozy-
gosity from those attributable to complete loss of Rbpj.
In all experiments, unless otherwise indicated, 10 mg TM was ad-
ministered to 6–8 week old adult mice, which were chased for 7 days
(short term) or 2 months (long term) (Fig. 1B). To monitor prolifera-
tion of labeled cells, mice used for 7 day chase experiments were also
continuously supplied with the thymidine analogue BrdU in the
drinking water, from 3 days prior to TM treatment through sacriﬁce.
This approach has previously been shown to capture all cells entering
S-phase during the chase period (Teta et al., 2007).
Inhibiting Notch in the small intestine causes overproduction of
goblet cells (Riccio et al., 2008; van Es et al., 2005), and we assayed
this phenotype as an indicator of successful Rbpj deletion. Hes1C2 is
active in intestinal stem cells (Kopinke et al., 2011), and deletion of
Rbpj with Hes1C2 caused robust transformation of the gut epithelium
into PAS-positive goblet cells (Figs. 1C–D). Importantly, the pancreata
of these mice exhibited no obvious morphological differences from
controls (Figs. 1E–F). To conﬁrm successful recombination in the pan-
creas, we performed PCR to detect the deletion (Δ) allele of Rbpj
(Fig. 1G). As expected, the deletion-speciﬁc product can be detected
in the pancreas and intestine of TM-treated RbpjHes1-lox mice, indicat-
ing recombination of the ﬂoxed allele.
Deletion of Rbpj in Hes1-expressing duct cells blocks their expansion
We previously showed that Hes1C2 marks not only CACs but also a
preferentially-expanding subset of cells within adult ducts, consistent
with a recent study suggesting that Jagged1-Notch signaling is mito-
genic for ducts (Golson et al., 2009; Kopinke et al., 2011). We there-
fore analyzed Rbpj knockouts for any defects of the ductal tree,
using the R26REYFP reporter allele to monitor the fate of cells deleting
Rbpj. This approach should allow us to quantitatively compare
RbpjHes1-lox to RbpjHes1-cKO cells by virtue of EYFP expression.
Fig. 1. Hes1-speciﬁc deletion of Rbpj in the pancreas and intestine. (A) Breeding strat-
egy for conditional knockout of Rbpj. Animals heterozygous for a null (Δ) and a ﬂoxed
(lox) allele of Rbpj (Rbpjlox/Δ) are abbreviated RbpjHes1-cKO, while Rbpjlox/+ mice serve as
controls (RbpjHes1-lox). In some experiments, RbpjΔ/+ mice were included as an addi-
tional control (RbpjHes1-het). All mice also carry a R26REYFP reporter allele, allowing for
lineage tracing of recombined cells. (B) Pulse-chase strategy. Recombination was in-
duced by TM administration in 6–8 week old adults and animals were chased for
7 days (short term) or 2 months (long term) before analyzing. (C–F) Comparison of
PAS-stained intestine (C–D) and H&E-stained pancreata (E–F) between RbpjHes1-lox
and RbpjHes1-cKO mice after a 7 day chase. Intestinal KO of Rbpj leads to widespread
transformation of the gut epithelium into PAS+ goblet cells. In contrast, no morpholog-
ical differences were detected between RbpjHes1-lox and RbpjHes1-cKO pancreata. (G) PCR
to detect recombination of ﬂoxed Rbpj. While the deletion-speciﬁc Rbpj ampliﬁcation
product (Δ) can be detected in tail DNA from Rbpjlox/Δ (lane l) but not Rbpj+/+ or
Rbpjlox/+ (lanes 2–3) mice, the Δ band can be ampliﬁed from the pancreas or duode-
num of an Rbpjlox/+ mouse after TM treatment (lanes 4–5). Abbreviations: ac, acinar;
is, islet; du, duct. Scale bar: 100 μm.
Fig. 2. Deletion of Rbpj inhibits expansion ofHes1C2-labeled ducts. (A–E) Adult RbpjHes1-lox
and RbpjHes1-cKO mice were treated with tamoxifen and stained for EYFP (green) and the
duct marker CK19 (red) after 7 days (A–B) and 2 months (C–D). While there is no differ-
ence in the fraction of EYFP-labeled duct cells (arrowheads) between 7 day chased
RbpjHes1-lox and RbpjHes1-cKO animals, an increase is detected between 7 days and
2 month in RbpjHes1-lox mice, which is inhibited in RbpjHes1-cKO animals (E). * Pb0.05. (F)
Quantiﬁcations of EYFP and BrdU labeling indices of intra- and interlobular ducts indicate
no differences between RbpjHes1-lox and RbpjHes1-cKOmice (P=0.75). (G) Quantiﬁcations of
EYFP and BrdU labeling indices of intercalated ducts, terminal ducts (TD) and centroacinar
cells (CACs) reveal a 2-fold decrease in EYFP labeling in RbpjHes1-cKO mice, as well as a
2-fold reduction in the fraction of cycling (BrdU+) EYFP-labeled intercalated ducts, TDs
and CACs. * Pb0.05. (H–I) EYFP (green) and BrdU (red) labeling of CK19+ CACs (white),
7 days post-TM and following a 10 day BrdU pulse. CACs expressing EYFP only
(open arrowheads) or positive for both EYFP and BrdU (closed arrowheads) can be
found in RbpjHes1-lox mice. In contrast, RbpjHes1-cKO animals have fewer EYFP+ CACs,
and most of the BrdU+ CACs are EYFP-negative (yellow arrowhead). Numbers in
bars (E–G) indicate mice analyzed per group. Scale bars: A–D and J, 100 μm; F–G,
50 μm.
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in the fraction of labeled CK19+ duct cells between 7 days and
2 months in RbpjHes1-lox mice. By comparison, the labeling index of
RbpjHes1-cKO ducts remained the same regardless of the chase period
(Figs. 2A–E; see also Table S1 for details on this and other quantitative
analyses), suggesting that the expansion of Hes1 lineage-derived
ducts requires Notch activity. The ductal tree can be divided into
proximal (intra- and interlobular) and distal ducts (intercalated
ducts, terminal ducts and CACs) (Kopinke and Murtaugh, 2010). To
determine if loss of Rbpj results in different outcomes at different po-
sitions within the ductal network, we analyzed RbpjHes1-lox and
RbpjHes1-cKO pancreata for the contribution of EYFP+ cells speciﬁcally
to proximal and distal ducts at 7 days post-TM. Since terminal ductsand CACs are phenotypically similar and difﬁcult to distinguish under
the microscope (Ekholm et al., 1962), we analyzed them together and
henceforth refer to them collectively as CACs. We found that although
the EYFP+ fraction of intra- and interlobular ducts did not changewith-
in 7 days of Rbpj deletion (Fig. 2F), Rbpj-deleted intercalated ducts and
CACs experienced an approximately 2-fold reduction in their EYFP la-
beling index (Fig. 2G). In addition, the fraction of EYFP-labeled cells
that had progressed through the cell cycle, as indicated by BrdU incor-
poration, did not change among proximal ducts but decreased ~2-fold
in distal ducts (Figs. 2F–I).
In wild-type pancreata, both the EYFP and BrdU labeling indices of
distal duct cells are approximately double those of proximal cells
(Figs. 2F–G). The fact that proliferation of distal cells declined to a
more proximal-like level, following Rbpj deletion, could reﬂect a mi-
togenic role for Notch in this population, but a change in proliferation
alone seemed insufﬁcient to explain the observed rapid decrease in
EYFP labeling of distal duct cells. Staining for cleaved Caspase-3
revealed minimal apoptosis in either genotype, after a 2 or 7 day post-
TM chase, with no increase upon Rbpj deletion (Fig. S1 and data not
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pearance of labeled cells from the distal ducts. To determine if loss of
Rbpj might cause necrosis or other injury of duct cells, we stained for
the exocrine lumenal marker Muc1, which is expressed preferentially
in distal ducts and acini (Kopinke and Murtaugh, 2010). Consistent
with the normal histological appearance of RbpjHes1-cKO pancreata
(Figs. 1E–F), we found no gross or subtle morphological abnormalities
in the Muc1+ ductal network following Rbpj deletion (Fig. S2). We
therefore considered the possibility that a subset of Rbpj-depleted distal
duct cells had adopted a non-ductal fate.
Dramatic increase of Hes1-labeled acinar cells after loss of Rbpj
Notch signaling inhibits embryonic islet cell development
(Apelqvist et al., 1999; Jensen et al., 2000), suggesting that Rbpj-
deleted CACs might adopt an endocrine fate. Nonetheless, we did
not detect a single insulin+ β-cell labeled by EYFP after a 7-day or
2-month chase in RbpjHes1-cKO mice, nor was there any increase in
the small fraction of glucagon+ α-cells normally labeled by Hes1C2
(Kopinke et al., 2011) (Fig. S3). We conclude that inhibiting Notch ac-
tivity does not permit CAC-to-islet differentiation. By contrast, casual
inspection revealed a considerable increase in EYFP labeling of
RbpjHes1-cKO acinar cells compared toRbpjHes1-lox (Figs. 3A–D). This effect
was quite rapid: within 7 days of tamoxifen administration, RbpjHes1-cKO
pancreata exhibited an approximately 3.5-fold increase in labeled aci-
nar cells, which did not increase further after 2 months (Fig. 3E). This
increase was not due to compound haploinsufﬁciency for Rbpj and
Hes1, as the acinar labeling index of RbpjHes1-hetmice was indistinguish-
able from RbpjHes1-lox. The increase in EYFP+ acinar cells was notFig. 3. Loss of Rbpj in Hes1+ cells results in dramatic increase of labeled acinar cells. (A–E)
(green) with the acinar marker amylase (red), 7 days (A–B) and 2 months (C–D) post-TM
and 2 months. In contrast, a drastic increase (~3.5-fold) in labeled acinar cells is seen bot
7 days post-TM. RbpjHes1-cKO animals display a 2-fold increase over RbpjHes1-lox in the fracti
Numbers in bars (E, H) indicate mice analyzed per group. Scale bars: A–D, 100 μm; F–G, 50accompanied by a detectable change in total pancreas mass despite
what should correspond to a 10% increase in total acinar numbers
(Fig. S4), although such a small change might be difﬁcult to detect in
the face of even modest experimental noise.
Notch signaling has previously been suggested to inhibit acinar
cell proliferation (Siveke et al., 2008). To determine whether the in-
creased acinar labeling in RbpjHes1-cKO could be attributed entirely to
division of rare Hes1C2-labeled acinar cells (Kopinke et al., 2011),
we analyzed BrdU incorporation rates in RbpjHes1-lox and RbpjHes1-cKO
mice (see above). After a 7 day chase, ~2% of EYFP+ acinar cells
were positive for BrdU in RbpjHes1-lox mice, compared to ~4% in
RbpjHes1-cKO mice (Figs. 3G–I). Because the initial fraction of BrdU+ aci-
nar cells even after continuous administration of BrdU for 10 days was
very low, and increased only to 4% in RbpjHes1-cKOmice, accelerated pro-
liferation of Hes1+ acinar cells cannot explain fully the dramatic in-
crease in EYFP+ acinar cells following Rbpj deletion.
To analyze acinar cells more directly, we deleted Rbpj using a TM-
inducible Cre line under control of the acinar-speciﬁc transcription
factor Ptf1a (Ptf1aCre-ERTM) (Fig. 4A). Immunostaining conﬁrmed that
all acinar cells expressed Ptf1a, including the subpopulation labeled
by Hes1C2 (Fig. 4B). Similar to our Hes1C2 breeding scheme (Fig. 1A),
we generated mice containing ﬂoxed and wild-type Rbpj alleles
(RbpjPtf1a-lox), or ﬂoxed and null alleles (RbpjPtf1a-cKO), all on a
R26REYFP/+ background (Fig. 4A). We found no difference between
RbpjPtf1a-lox and RbpjPtf1a-cKO in the EYFP labeling of acinar cells at
7 days post-TM (Figs. 4C–E). Using the same BrdU labeling scheme as
above, we also detected no change in the fraction of EYFP-expressing,
BrdU+ acinar cells between genotypes (Fig. 4F). These results argue
against a role for Notch in regulating proliferation of mature acinarAdult RbpjHes1-lox and RbpjHes1-cKO pancreata were analyzed for co-expression of EYFP
. The fraction of EYFP+ acini in RbpjHes1-lox animals remains constant between 7 days
h 7 days and 2 months after loss of Rbpj (E). * Pb0.005. (F–H) BrdU/EYFP labeling at
on of EYFP+ acinar cells that have incorporated BrdU (white arrowheads). * Pb0.005.
μm.
Fig. 4. No increased proliferation after acinar-speciﬁc loss of Rbpj. (A) To determine whether Notch generally represses expansion of acinar cells, Rbpjwas deleted using an inducible
Ptf1aCre-ERTM Cre driver, which induces mosaic recombination in acinar cells but not ducts or CACs. Blue, acinar cells; red, CAC; green, Ptf1a lineage-labeling. (B) Short term lineage
tracing of Hes1+ cells (green) demonstrates that all EYFP+ acinar cells (arrowheads) also express Ptf1a (white). (C–D) At 7 days post-TM, no difference is detected, between
RbpjPtf1a-lox and RbpjPtf1a-cKO, in EYFP labeling (green) of amylase+ acinar cells (red). (E) There is no change in the fraction of EYFP+ acinar cells after a 7 day chase (P=0.52).
(F) Quantiﬁcation of BrdU labeling analysis 7 days post-TM. The EYFP/BrdU labeling index of acinar cells remains the same between control (lox and het) and Ptf1a1-KO animals
(P=0.81). Numbers in bars (E–F) indicate mice analyzed per group. Scale bars: B, 50 μm; C–D, 100 μm.
61D. Kopinke et al. / Developmental Biology 362 (2012) 57–64cells, and raise the possibility of a Notch-regulated inﬂux to the acinar
compartment from another cell type.
Loss of Rbpj causes rapid transformation of CAC into acinar cells
The disappearance of EYFP+ intercalated ducts and CACs (Fig. 2),
and our ﬁnding that Notch does not inhibit acinar proliferation
(Fig. 4), prompted us to investigate whether the observed increase
of EYFP+ acinar cells in RbpjHes1-cKO mice was due to a cell fate switch
of CACs (Fig. 5A). To analyze individual acinar units, and avoid miss-
ing small CACs due to sectioning artifacts, we performed enzymatic
digestion to dissociate the pancreas into clusters containing only aci-
nar cells and CACs (referred to as acinar preps; Fig. 5B) (Kopinke and
Murtaugh, 2010; Kurup and Bhonde, 2002). Immediately after diges-
tion, acinar preps were spun onto slides, ﬁxed and processed for
immunostaining. Using this method, we scored two major categories
of clusters at 7 days post-TM treatment, based on the presence (class
1) or absence (class 2) of EYFP-labeled CACs. Class 1 comprised clus-
ters in which only CACs were labeled (1a) or in which both CACs andacini were labeled (1b). Class 2 comprised clusters containing labeled
acini with unlabeled CACs (2a) or labeled acini with no CACs at all
(2b). If CACs were converting to acinar cells after Rbpj deletion, we
would expect a decrease in class 1 clusters and an increase in class
2. Indeed, we found that the majority of RbpjHes1-lox clusters were of
class 1, while class 2 predominated in RbpjHes1-cKO (Figs. 5G–H). Quan-
tiﬁcation revealed a 3.5-fold reduction, in RbpjHes1-cKO mice, of the
class 1 cluster frequency, and a concomitant increase (2.5-fold) of
class 2 clusters (Fig. 5I), suggesting that CACs convert to acinar cells
after loss of Rbpj.
If CACs were indeed capable of adopting an acinar fate, we should
observe transitional cells expressing both duct and acinar markers. By
analyzing acinar preps from a 48 h chase, we were able to detect
EYFP+ cells co-expressing the duct marker CK19 and the mature aci-
nar marker amylase in RbpjHes1-cKO mice speciﬁcally (Figs. 5J–K). At
later chase time points, we no longer observed EYFP-labeled cells
co-expressing CK19 and amylase, nor were such cells observed in
RbpjHes1-lox acinar preps at any time point. Thus, loss of Rbpj in CACs
causes a rapid transition to an acinar fate.
Fig. 5. Hes1+CACs contribute to acinar cells upon Rbpj deletion. (A)Wehypothesize that the increase in acinar labeling after loss ofRbpj is due to CACs adopting an acinar fate. Blue, acinar
cells; red, CAC; green, Hes1 lineage-labeling. (B) Dissociation of whole pancreata generates small clusters containing amylase+ acinar cells (white) and CK19+ CACs (red). (C) Clusters
fromHes1 lineage traced (green) pancreata were divided into twomajor categories, based on the presence (class 1) or absence (class 2) of labeled CACs as indicated. Class 1 clusters con-
tain EYFP+ CACswith acinar cells unlabeled (1a) or EYFP+ CACs and acinar cells together (1b), while class 2 clusters contain EYFP+ acinar cells with unlabeled CACs (2a) or EYFP+ acinar
cells with no CACs present (2b). Inserts represent schematic representations of cluster types. (D–E) Immunoﬂuorescence for EYFP (green) and CK19 (red) of clusters from dissociated
pancreata of RbpjHes1-lox and RbpjHes1-cKO animals at 7 days post-TM. Only clusters containing 3 or more closely-attached acinar cells were scored (circle). Most of the RbpjHes1-lox clusters
contain labeled CAC (arrowhead) and belong to class 1, while CACs are either unlabeled or absent altogether in RbpjHes1-cKO clusters (classes 2a and 2b). (F) Scoring of cluster types from
two independent experiments demonstrates a shift in the proportion of clusters from types 1a and 1b to 2a and 2b between RbpjHes1-lox and RbpjHes1-cKOmice (*Pb0.0005). Note that the
denominator represents the number of total clusters present per ﬁeld, including entirely EYFP-negative ones. (G–H) Immunoﬂuorescence for amylase (white) and CK19 (red) of cell clus-
ters from RbpjHes1-lox (J) and RbpjHes1-cKO (K) pancreata 48 h after TM administration. In RbpjHes1-lox mice (J), CK19 and amylase expression are restricted to CAC and acinar cells, respec-
tively. After TM induction (K), some amylase+ acinar cells are also positive for CK19 (dotted outline). Co-expression of duct and acinar markers is seen only in EYFP+ cells (right).
Right, single-channel amylase, CK19, EYFP and DAPI staining as indicated. Numbers in bars (I) indicate mice analyzed per group. Scale bar: D–E, 50 μm; G–H, 25 μm.
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The mammalian pancreas is a generally static organ, and numer-
ous studies support replication as the major mode of postnatal expan-
sion, adult homeostasis and regeneration (Brennand et al., 2007;
Desai et al., 2007; Dor et al., 2004; Georgia and Bhushan, 2004;
Kopinke and Murtaugh, 2010; Solar et al., 2009; Strobel et al., 2007;
Teta et al., 2007). Nonetheless, adult cell fates can be overridden by
the ectopic activation of developmental regulatory factors
(Collombat et al., 2009; De La O et al., 2008; Zhou et al., 2008).
While such gain-of-function experiments reveal the potential of
adult cells to change fates, they do not address the mechanisms by
which lineages normally maintain phenotypic ﬁdelity. Here, we pro-
vide evidence that an endogenous signaling pathway acts to prevent
cell type interconversion in the adult pancreas.
Notch signaling regulates cell fate decisions in numerous contexts,
in some cases promoting one fate at the expense of another while inothers suppressing differentiation altogether (Chiba, 2006). In the in-
testine, for example, Notch is not only required for absorptive cell
speciﬁcation but also to maintain a self-renewing stem cell compart-
ment (Riccio et al., 2008; van Es et al., 2005). Similarly, Notch acts
during early pancreas development to suppress progenitor cell differ-
entiation, while in later organogenesis it promotes duct development
at the expense of acinar (Esni et al., 2004; Hald et al., 2003; Kopinke
et al., 2011; Murtaugh et al., 2003; Yee et al., 2005). We have previ-
ously shown that Hes1 lineage-derived cells represent a preferentially
expanding population within the adult duct epithelium (Kopinke
et al., 2011), suggesting that Notch might act in the adult primarily
as a ductal mitogen. Surprisingly, we ﬁnd that although Hes1IC2 is
expressed in both proximal and distal duct cells, indicating Notch ac-
tivity, deletion of Rbpj impairs proliferation of distal duct cells specif-
ically (Fig. 2). These ﬁndings raise the possibility that Rbpj-mediated
Notch signaling does not directly regulate proliferation of main duct
cells, but instead drives the maintenance of a distal centroacinar cell
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growth.
While this model emphasizes the cell fate determination role of
Notch signaling in the adult pancreas, it leaves open the question of
why CACs should retain the ability to generate acinar cells. Histolog-
ical studies previously suggested that CACs could give rise to β-cells
following injury, implicating this cell type as a facultative progenitor
(Hayashi et al., 2003; Nagasao et al., 2003), and CACs have more re-
cently been shown to have a unique capacity for multi-lineage differ-
entiation in vitro (Rovira et al., 2010). Intriguingly, the cells isolated
in that study were actually Hes1-negative (Rovira et al., 2010), consis-
tent with the possibility that Hes1 is normally expressed by CACs with
restricted differentiation potential. It will be interesting to decipher
the lineage relationship, if any, between Hes1-positive and -negative
CACs, and to determine whether the latter population contributes to
new acinar cells in vivo.
Taken together, our lineage tracing and Rbpj knockout results sug-
gest that Hes1 lineage-derived CACs behave as bipotent, exocrine-
restricted progenitor cells, similar to Hes1-expressing cells in the
late embryonic pancreas (Kopinke et al., 2011), with their acinar dif-
ferentiation potential suppressed by constitutive Notch signaling. Are
there circumstances in which wild-type CACs might reacquire acinar
potential? One possibility is that CACs represent an “emergency re-
serve” for replacement of acinar cells lost to injury, and that sustained
Notch signaling ensures that these cells remain available. Intriguingly,
Notch activity is required for regeneration from caerulein-induced
pancreatitis (Siveke et al., 2008), which might reﬂect the role of
Notch in maintaining Hes1+ CACs. Although lineage tracing analyses
indicate that regeneration from pancreatitis is driven primarily by
proliferation of surviving acinar cells (Desai et al., 2007; Strobel et
al., 2007), a recent study suggests that more extreme acinar loss can
be repaired by differentiation of non-acinar cells, most likely ducts
(Criscimanna et al., 2011). Our ﬁndings provide a basis to address
the role of Hes1-expressing CACs and Notch signaling in regeneration,
and raise the question of whether other pathways controlling pancre-
atic organogenesis continue to play analogous roles in postnatal life.
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